Itron - ITRI Stock Forecast, Price & News

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Itron in the last twelve months. There are currently 1 sell rating, 4 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ITRI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ITRI, but not buy additional shares or sell existing shares.
View ITRI analyst ratings or view top-rated stocks.

8 Wall Street analysts have issued 1 year price targets for Itron's stock. Their ITRI share price forecasts range from $45.00 to $72.00. On average, they expect the company's stock price to reach $57.22 in the next twelve months. This suggests a possible upside of 3.2% from the stock's current price.
View analysts price targets for ITRI or view top-rated stocks among Wall Street analysts.

Itron's stock was trading at $50.65 at the beginning of 2023. Since then, ITRI shares have increased by 9.5% and is now trading at $55.45.
View the best growth stocks for 2023 here.

Itron saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 1,550,000 shares, an increase of 11.5% from the February 28th total of 1,390,000 shares. Based on an average trading volume of 259,600 shares, the short-interest ratio is presently 6.0 days. Approximately 3.5% of the shares of the company are short sold.
View Itron's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our ITRI earnings forecast.

Itron, Inc. (NASDAQ:ITRI) posted its quarterly earnings data on Monday, February, 27th. The scientific and technical instruments company reported $0.71 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.62. The scientific and technical instruments company had revenue of $467.50 million for the quarter, compared to the consensus estimate of $433.90 million. Itron had a positive trailing twelve-month return on equity of 4.41% and a negative net margin of 0.54%. The business's quarterly revenue was down 3.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.75 earnings per share.

ETFs with the largest weight of Itron (NASDAQ:ITRI) stock in their portfolio include SPDR S&P Kensho Intelligent Structures ETF (SIMS), SmartETFs Sustainable Energy II ETF (SOLR), First Trust Water ETF (FIW), ALPS Clean Energy ETF (ACES), Neuberger Berman Carbon Transition & Infrastructure ETF (NBCT), Invesco S&P SmallCap Information Technology ETF (PSCT), Gabelli Automation ETF (GAST) and Global X Internet of Things Thematic ETF (SNSR).

Itron updated its first quarter 2023 earnings guidance on Monday, February, 27th. The company provided earnings per share guidance of $0.05-$0.15 for the period, compared to the consensus EPS estimate of $0.21. The company issued revenue guidance of $460.00 million-$475.00 million, compared to the consensus revenue estimate of $450.96 million.

3 employees have rated Itron Chief Executive Officer Tom Deitrich on Glassdoor.com. Tom Deitrich has an approval rating of 100% among the company's employees. This puts Tom Deitrich in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Itron investors own include NVIDIA (NVDA), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Applied Materials (AMAT), QUALCOMM (QCOM), Xilinx (XLNX), Intel (INTC), AT&T (T) and Tesla (TSLA).

Itron trades on the NASDAQ under the ticker symbol "ITRI."

Itron's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Amundi (5.76%), Schroder Investment Management Group (3.14%), First Trust Advisors LP (1.92%), Geode Capital Management LLC (1.91%), Neuberger Berman Group LLC (1.86%) and Aristotle Capital Boston LLC (1.79%). Insiders that own company stock include Christopher E Ware, Donald L Reeves III, Joan S Hooper, John F Marcolini, John F Marcolini, Lynda L Ziegler, Michel Cadieux, Sarah E Hlavinka, Sharelynn Faye Moore, Thomas Deitrich and Thomas S Glanville.
View institutional ownership trends.

Shares of ITRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ITRI stock can currently be purchased for approximately $55.45.

Itron (NASDAQ:ITRI) has a market capitalization of $2.52 billion and generates $1.80 billion in revenue each year. The scientific and technical instruments company earns $-9,730,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis.

The company employs 5,477 workers across the globe.

Itron's mailing address is 2111 N MOLTER ROAD, LIBERTY LAKE WA, 99019. The official website for the company is www.itron.com. The scientific and technical instruments company can be reached via phone at (509) 924-9900, via email at investors@itron.com, or via fax at 509-891-3355.